GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (OSTO:ALZCUR) » Definitions » Float Percentage Of Total Shares Outstanding

AlzeCure Pharma AB (OSTO:ALZCUR) Float Percentage Of Total Shares Outstanding : 0.00% (As of Sep. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is AlzeCure Pharma AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, AlzeCure Pharma AB's float shares is 0.00 Mil. AlzeCure Pharma AB's total shares outstanding is 88.30 Mil. AlzeCure Pharma AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, AlzeCure Pharma AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, AlzeCure Pharma AB's Institutional Ownership is 0.02%.

AlzeCure Pharma AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

AlzeCure Pharma AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/88.30
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AlzeCure Pharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (OSTO:ALZCUR) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
OSTO:MOB OSTO:ERMA OSTO:VIVE XSAT:PMED XSAT:ODI XSAT:DICOT OSTO:NANEXA OSTO:NEWBRY OSTO:KLAR OSTO:RLS ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
AC6:Germany
Address
Halsovagen 7, Huddinge, SWE, SE 141 57
Website
https://www.alzecurepharma.se
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms NeuroRestore, Alzstatin, and Painless. The company's drug candidates include; ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, ACD679, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatment of severe pain in conditions such as osteoarthritis.

AlzeCure Pharma AB Headlines

No Headlines